EyeGate Pharmaceuticals, Inc. (EYEG)
USD 33.92
(-1.47%)
USD 33.92
(-1.47%)
| Breakdown | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|
| Revenue | 12.05 Thousand | 2.68 Million | 1.65 Million | 407.51 Thousand | 669.25 Thousand | - |
| Cost of Revenue | 12.04 Thousand | - | - | - | - | - |
| Gross Profit | 13.00 | 2.68 Million | 1.65 Million | 407.51 Thousand | 669.25 Thousand | - |
| Operating Expenses | 8.22 Million | 9.79 Million | 12.49 Million | 14.96 Million | 14.01 Million | 6.67 Million |
| Selling, General and Administrative Expenses | 4.65 Million | 4.4 Million | 4.44 Million | 4.63 Million | 5.59 Million | 3.96 Million |
| Research and Development Expenses | 3.56 Million | 5.38 Million | 8.05 Million | 10.33 Million | 8.42 Million | 2.71 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.22 Million | 9.79 Million | 12.49 Million | 14.96 Million | 14.01 Million | 6.67 Million |
| Operating Income | -8.21 Million | -7.1 Million | -10.84 Million | -14.55 Million | -13.34 Million | -6.67 Million |
| Interest Expense | 4186.00 | 325.00 | 1040.00 | 1215.00 | 275.00 | 1.93 Million |
| Income Tax Expense | 12.05 Thousand | 95.39 Thousand | 86.04 Thousand | -1.34 Million | 3684.00 | 224.12 Thousand |
| Earnings before Tax | -8.07 Million | -7 Million | -10.72 Million | -14.55 Million | -13.34 Million | -8.38 Million |
| Net Income | -8.09 Million | -7.09 Million | -10.81 Million | -13.21 Million | -13.34 Million | -8.39 Million |
| Earnings Per Share Basic | -2.54 | -2.23 | -4.57 | -13.90 | -22.66 | -18.14 |
| Earnings Per Share Diluted | -2.54 | -2.23 | -4.57 | -13.90 | -22.66 | -18.14 |
| Weighted Average Shares Outstanding | 3.18 Million | 3.18 Million | 2.36 Million | 950.67 Thousand | 588.92 Thousand | 462.74 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.18 Million | 3.18 Million | 2.36 Million | 950.67 Thousand | 588.92 Thousand | 462.74 Thousand |
| Gross Margin | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | -666.91 | -2.53 | -6.47 | -35.68 | -19.93 | - |
| Profit Margin | -671.03 | -2.64 | -6.54 | -32.44 | -19.94 | - |
| EBITDA | -8.04 Million | -6.78 Million | -10.68 Million | -14.53 Million | -13.33 Million | -6.45 Million |
| Earnings Before Tax Margin | -681.05 | -2.65 | -6.56 | -35.73 | -19.94 | - |
| Breakdown | 2024 Q2 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 FY | 2020 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 20 Thousand | - | - | - | 12.05 Thousand | 12.05 Thousand |
| Cost of Revenue | - | - | - | - | 12.04 Thousand | - |
| Gross Profit | 20 Thousand | - | - | - | 13.00 | 12.05 Thousand |
| Operating Expenses | 2.56 Million | 2.96 Million | 2.74 Million | 2.58 Million | 8.22 Million | 2.52 Million |
| Selling, General and Administrative Expenses | 1.53 Million | 1.33 Million | 1.3 Million | 1.3 Million | - | 1.51 Million |
| Research and Development Expenses | 906.68 Thousand | 1.62 Million | 1.43 Million | 1.28 Million | - | 1.01 Million |
| Other Expenses | 120.23 Thousand | - | - | - | - | - |
| Cost and Expenses | 2.56 Million | 2.96 Million | 2.74 Million | 2.58 Million | 8.22 Million | 2.52 Million |
| Operating Income | -2.54 Million | -2.96 Million | -2.74 Million | -2.58 Million | -8.21 Million | -2.51 Million |
| Interest Expense | - | - | 2033.00 | 686.00 | 4186.00 | 4186.00 |
| Income Tax Expense | - | 259.00 | 278.52 Thousand | 250.00 | 12.05 Thousand | - |
| Earnings before Tax | -2.22 Million | -2.96 Million | -2.46 Million | -2.58 Million | -8.07 Million | -2.4 Million |
| Net Income | -2.22 Million | -2.96 Million | -2.46 Million | -2.58 Million | -8.09 Million | -2.41 Million |
| Earnings Per Share Basic | -0.53 | -0.42 | -0.35 | -0.37 | - | -0.53 |
| Earnings Per Share Diluted | -0.53 | -0.42 | -0.35 | -0.37 | - | -0.53 |
| Weighted Average Shares Outstanding | 4.17 Million | 7.06 Million | 7.06 Million | 6.95 Million | 3.18 Million | 4.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.17 Million | 7.06 Million | 7.06 Million | 6.95 Million | 3.18 Million | 4.54 Million |
| Gross Margin | 1.00 | - | - | - | 0.00 | 1.00 |
| EBIT Margin | -127.24 | - | - | - | - | -199.23 |
| Profit Margin | -111.08 | - | - | - | -671.03 | -200.33 |
| EBITDA | -2.54 Million | -2.95 Million | -2.45 Million | -2.56 Million | - | -2.4 Million |
| Earnings Before Tax Margin | -127.24 | - | - | - | -681.05 | -208.43 |
UOLGY
TS0U
NRC
9651
RES
RISE